Serum CrossLaps for monitoring the response in individuals undergoing antiresorptive therapy
- 18 April 2000
- Vol. 26 (5), 505-511
- https://doi.org/10.1016/s8756-3282(00)00248-9
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Biochemical Markers of Bone Turnover and Prediction of Hip Bone Loss in Older Women: The Study of Osteoporotic FracturesJournal of Bone and Mineral Research, 1999
- The effect of modifying dietary calcium intake pattern on the circadian rhythm of bone resorption.Calcified Tissue International, 1999
- Comparison of urinary bone resorption markers in women of 40–70 years; day-to-day and long-term variation in individual subjectsMaturitas, 1998
- Postmenopausal bone remodelling and hormone replacement.Climacteric, 1998
- Effects of Raloxifene on Bone Mineral Density, Serum Cholesterol Concentrations, and Uterine Endometrium in Postmenopausal WomenNew England Journal of Medicine, 1997
- Bone Biomarkers as Tools in Osteoporosis ManagementSpine, 1997
- Characterization of Urinary Degradation Products Derived from Type I CollagenJournal of Biological Chemistry, 1997
- Comparison of semiquantitative visual and quantitative morphometric assessment of prevalent and incident vertebral fractures in osteoporosisJournal of Bone and Mineral Research, 1996
- Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessmentJournal of Clinical Endocrinology & Metabolism, 1995
- Comparison of new biochemical markers of bone turnover in late postmenopausal osteoporotic women in response to alendronate treatmentJournal of Clinical Endocrinology & Metabolism, 1994